ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保險業中免疫生物股份正在繼續增強，週四宣佈在多個州提供ANKTIVA的保險覆蓋後，首次商業劑量已經投放。
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保險業中免疫生物股份正在繼續增強，週四宣佈在多個州提供ANKTIVA的保險覆蓋後，首次商業劑量已經投放。